These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7154724)

  • 21. [Can measurement of basal calcitonin replace the pentagastrin test?].
    Vestergaard P; Jönsson AL; Christiansen P; Frohnert J
    Ugeskr Laeger; 2008 Oct; 170(41):3238-42. PubMed ID: 18940156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma somatostatin activity in medullary cancer of the thyroid.
    Neradilová M; Nĕmec J; Zamrazil V; Bednár J; Pechová M; Soutorová M
    Oncology; 1989; 46(6):378-80. PubMed ID: 2573874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of octreotide in the treatment of medullary thyroid carcinoma.
    Frank-Raue K; Ziegler R; Raue F
    Horm Metab Res Suppl; 1993; 27():44-7. PubMed ID: 8330871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol-stimulated calcitonin release in medullary carcinoma of the thyroid.
    Cohen SL; MacIntyre I; Grahame-Smith D; Walker JG
    Lancet; 1973 Nov; 2(7839):1172-3. PubMed ID: 4127549
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
    Diez JJ; Iglesias P
    Thyroid; 2004 Nov; 14(11):984-5. PubMed ID: 15678599
    [No Abstract]   [Full Text] [Related]  

  • 27. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Useful and limits of the biochemical markers for the diagnosis of thyroid carcinoma].
    Colombo P; Locatelli F; Travaglini P
    Ann Ital Chir; 2006; 77(3):209-14. PubMed ID: 17137035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of intraoperative pentagastrin testing in medullary thyroid cancer.
    Scheuba C; Bieglmayer C; Asari R; Kaczirek K; Izay B; Kaserer K; Niederle B
    Surgery; 2007 Feb; 141(2):166-71; discussion 171-2. PubMed ID: 17263971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interference in radioimmunoassay of human calcitonin by vitamin C and urea.
    Morimoto S; Onishi T; Takamoto S; Imanaka S; Fukuo K; Tsuchiya H; Koh E; Yukawa S; Kumahara Y
    Med J Osaka Univ; 1985 Mar; 35(3-4):77-82. PubMed ID: 4069062
    [No Abstract]   [Full Text] [Related]  

  • 31. [Medullary thyroid carcinoma--familial or sporadic disease?].
    Høie J; Jørgensen OG; Nesland JM; Møller P; Bjøro K
    Tidsskr Nor Laegeforen; 1994 Oct; 114(25):2951-4. PubMed ID: 7974404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
    Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
    Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
    Mirallié E; Iacobone M; Sebag F; Henry JF
    Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early diagnosis of occult medullary carcinoma of the thyroid by immunoreactive thyrocalcitonin detection.
    Fiorillo A; Migliorati R; Lombardi G
    Acta Paediatr Scand; 1980 Sep; 69(5):693-4. PubMed ID: 7234393
    [No Abstract]   [Full Text] [Related]  

  • 35. Elevated basal calcitonin levels in a patient with a hurthle-cell carcinoma of the thyroid and neuroendocrine differentiation: report of a case.
    Munitiz V; Martinez-Barba E; Riquelme J; Rodriguez JM; Piñero A; Parrilla P
    Surg Today; 2005; 35(5):404-6. PubMed ID: 15864423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meal-related changes in plasma calcitonin levels in patients with medullary thyroid carcinoma.
    Miyauchi A; Morimoto S; Onishi T; Takai S; Okada Y; Himeno S; Kosaki G; Kumahara Y
    Endocrinol Jpn; 1980 Apr; 27(2):153-6. PubMed ID: 7190894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical results of reoperations for medullary thyroid carcinoma.
    Fernandez Vila JM; Peix JL; Mandry AC; Mezzadri NA; Lifante JC
    Laryngoscope; 2007 May; 117(5):886-9. PubMed ID: 17473689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medullary thyroid carcinoma.
    Evans DB; Burgess MA; Goepfert H; Gagel RF
    Curr Ther Endocrinol Metab; 1997; 6():127-32. PubMed ID: 9174720
    [No Abstract]   [Full Text] [Related]  

  • 39. [MEN 2A syndrome: report of a family].
    Krassowski J; Gabryelewicz MB; Jeske W; Zgliczyński S
    Pol Merkur Lekarski; 2000 Jul; 8(49):481-2. PubMed ID: 11070721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance of plasma calcitonin for the clinical diagnosis].
    Dambacher MA; Hunziker W; Fischer JA
    Dtsch Med Wochenschr; 1977 Aug; 102(33):1191-3. PubMed ID: 891418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.